406 related articles for article (PubMed ID: 11345042)
1. Cysteine proteinase inhibitor level in tumor and normal tissues in control and cured mice.
Poteryaeva ON; Falameyeva OV; Korolenko TA; Kaledin VI; Djanayeva SJ; Nowicky JW; Sandula J
Drugs Exp Clin Res; 2000; 26(5-6):301-6. PubMed ID: 11345042
[TBL] [Abstract][Full Text] [Related]
2. Cystatin C in LS lymphosarcoma and HA-1 hepatoma treated with Ukrain and cyclophosphamide and involvement of apoptosis.
Korolenko TA; Poteryaeva ON; Djanayeva SJ; Svechnikova IG; Kaledin VI; Timofeyeva OA; Filipenko ML; Nowicky J
Drugs Exp Clin Res; 2000; 26(5-6):285-92. PubMed ID: 11345040
[TBL] [Abstract][Full Text] [Related]
3. Influence of Ukrain and cyclophosphamide administration on HA-1 murine hepatoma and LS lymphoma on aspartic proteinase cathepsin D.
Djanayeva SJ; Korolenko TA; Svechnikova IG; Falameyeva OV; Korolenko E; Kaledin VI; Nowicky J
Drugs Exp Clin Res; 2000; 26(5-6):293-9. PubMed ID: 11345041
[TBL] [Abstract][Full Text] [Related]
4. [Cysteine proteinases and their inhibitors in the development of mouse HA-1 hepatoma and antineoplastic therapy].
Poteriaeva ON; Korolenko TA; Svechnikova IG; Zhanaeva SIa; Falameeva OV; Kaledin VI; Nowicky JW
Biomed Khim; 2004; 50(2):172-9. PubMed ID: 15179824
[TBL] [Abstract][Full Text] [Related]
5. Chitotriosidase as a new marker of macrophage stimulation in a tumor model treated with cyclophosphamide and Ukrain.
Korolenko TA; Djanayeva SJ; Falameyeva OV; Wevers RA; Filjushina EE; Buzueva II; Kaledin VI; Sandula J; Nowicky J
Drugs Exp Clin Res; 2000; 26(5-6):279-83. PubMed ID: 11345039
[TBL] [Abstract][Full Text] [Related]
6. The influence of Ukrain on the growth of HA-1 tumor in mice: the role of cysteine proteinases as markers of tumor malignancy.
Svechnikova IG; Korolenko TA; Stashko JuF ; Kaledin VI; Nikolin VP; Nowicky JW
Drugs Exp Clin Res; 1998; 24(5-6):261-9. PubMed ID: 10190085
[TBL] [Abstract][Full Text] [Related]
7. The dynamics of concentration of the main fluorescent component of Ukrain in the tissues and blood plasma of rats with W-256 tumor after a single intravenous injection.
Doroshenko YM; Karavay AV; Hodysh YY; Uglyanitsa KN; Nowicky WM; Nefyodov LI
Drugs Exp Clin Res; 2000; 26(5-6):171-7. PubMed ID: 11345024
[TBL] [Abstract][Full Text] [Related]
8. Macrophage stimulation and antitumor effect of Ukrain.
Korolenko TA; Svechnikova IG; Filjushina EE; Kaledin VI; Vakulin GM; Usynin IF; Tsyrendordjiev DD
Drugs Exp Clin Res; 1998; 24(5-6):253-60. PubMed ID: 10190084
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of blood plasma and tumor tissue amino acid pool in radiation or neoadjuvant preoperative therapies of breast cancer with the antitumor drug Ukrain.
Nefyodov LI; Uglyanitsa KN; Smirnov VY; Karavay AV; Brzosko W
Drugs Exp Clin Res; 2000; 26(5-6):231-7. PubMed ID: 11345030
[TBL] [Abstract][Full Text] [Related]
10. Study of the antitumor effect of Ukrain: the role of macrophage secretion of alpha-1-proteinase inhibitor.
Korolenko TA; Kaledin VI; Svechnikova IG; Li XV; Stashko JF; Ilnitskaya SI; Nikolin VP
Drugs Exp Clin Res; 1998; 24(5-6):271-6. PubMed ID: 10190086
[TBL] [Abstract][Full Text] [Related]
11. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
Liepins A; Nowicky JW
Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
[TBL] [Abstract][Full Text] [Related]
12. Cystein proteinase inhibitor stefin A as an indicator of efficiency of tumor treatment in mice.
Korolenko TA; Poteryaeva ON; Falameeva OV; Levina OA
Bull Exp Biol Med; 2003 Jul; 136(1):46-8. PubMed ID: 14534608
[TBL] [Abstract][Full Text] [Related]
13. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
14. Ukrain both as an anti cancer and immunoregulatory agent.
Nowicky JW; Manolakis G; Meijer D; Vatanasapt V; Brzosko WJ
Drugs Exp Clin Res; 1992; 18 Suppl():51-4. PubMed ID: 1305045
[TBL] [Abstract][Full Text] [Related]
15. New biochemical mechanisms of the anticancer effect of Ukrain in the treatment of cancer of the urinary bladder.
Nefyodov LI; Uglyanitsa KN; Nechiporenko NA; Smirnov VY; Brzosko W; Karavay NL
Drugs Exp Clin Res; 2000; 26(5-6):195-9. PubMed ID: 11345027
[TBL] [Abstract][Full Text] [Related]
16. Serum cystatin C in patients with head and neck carcinoma.
Strojan P; Svetic B; Smid L; Kos J
Clin Chim Acta; 2004 Jun; 344(1-2):155-61. PubMed ID: 15149884
[TBL] [Abstract][Full Text] [Related]
17. Ukrain (NSC-631570) in the treatment of pancreas cancer.
Zemskov VS; Procopchuk OL; Susak YM; Zemskov SV; Hodysh YY; Zemskova MV
Drugs Exp Clin Res; 2000; 26(5-6):179-90. PubMed ID: 11345025
[TBL] [Abstract][Full Text] [Related]
18. Effect of Ukrain on the growth and metastasizing of Lewis carcinoma in C57BL/6 mice.
Grinevich Y; Shalimov S; Bendyuh G; Zahriychuk O; Hodysh Y
Drugs Exp Clin Res; 2005; 31(2):59-70. PubMed ID: 15929607
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of the efficiency of various Ukrain doses in the combined treatment of breast cancer. Report 1. Clinical aspects of Ukrain application.
Uglyanitsa KN; Nefyodov LI; Brzosko V
Drugs Exp Clin Res; 2000; 26(5-6):223-30. PubMed ID: 11345029
[TBL] [Abstract][Full Text] [Related]
20. Expression of cysteine proteinases cathepsins B and K and of cysteine proteinase inhibitor cystatin C in giant cell tumor of tendon sheath.
Hansen T; Petrow PK; Gaumann A; Keyszer GM; Otto M; Kirkpatrick CJ; Kriegsmann J
Mod Pathol; 2001 Apr; 14(4):318-24. PubMed ID: 11301348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
